BPBT
ANIK icon

Boston Private Bank & Trust’s Anika Therapeutics ANIK Stock Holding History

Boston Private Bank & Trust’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-700
Closed -$29K – 985
2014
Q1 		$29K Buy
+700
New +$26K ﹤0.01% 686

Other funds holding ANIK

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Boston Private Bank & Trust's ANIK Position: Q2 2014 in Review

Boston Private Bank & Trust sold out of Anika Therapeutics (ANIK) in Q2 2014, closing a stake of 700 shares — an estimated $29K sold.

Boston Private Bank & Trust first reported a position in ANIK in Q1 2014 and held it in 1 quarter. The position peaked at $29K in Q1 2014. 162 funds tracked by Wall St. Rank hold ANIK as of Q2 2014.

  • Boston Private Bank & Trust reported no remaining Anika Therapeutics position as of Q2 2014 after selling out during the quarter.
  • Boston Private Bank & Trust sold 700 Anika Therapeutics shares in Q2 2014, an estimated $29K.
  • Boston Private Bank & Trust first reported a position in Anika Therapeutics in Q1 2014 and held it in 1 quarter.
  • Boston Private Bank & Trust's Anika Therapeutics position peaked at $29K in Q1 2014.
  • 162 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2014.

Based on Boston Private Bank & Trust's 13F filing for Q2 2014, filed 15 Jul 2014.